Leukemia - Featured Clinical Trials
The following list shows Featured Clinical Trials for a specific type of cancer. You may also want to view:
- Oblimersen Treatment for Older Patients with AML
(Posted: 04/05/2005) - In this trial, researchers are trying to determine whether adding the drug oblimersen (Genasense) to chemotherapy will improve survival in patients aged 60 and older who have previously untreated AML.
- Improving Allogeneic Stem Cell Transplantation
(Posted: 02/22/2005) - In this study, researchers are testing whether a modified transplantation regimen may reduce complications while preserving the benefits of haploidentical allogeneic stem cell transplantation.
- Immunotoxin Therapy for Acute Myeloid Leukemia
(Posted: 01/25/2005) - In this trial, researchers are testing whether addition of an immunotoxin, gemtuzumab ozogamicin, to standard chemotherapy will improve the disease-free survival of patients with previously untreated AML.
- Treating Mouth Sores in Pediatric Chemotherapy Patients
(Posted: 12/14/2004) - This trial is testing a homeopathic mouth rinse as a treatment for mucositis in young patients undergoing chemotherapy in preparation for stem cell transplantation.
- Study of Individuals and Families at High Risk for Blood Cancers
(Posted: 07/27/2004) - Researchers want to study individuals and families who may have a genetic predisposition to developing hematologic cancers. Studying this population may help identify other persons at risk, precursor conditions, clues to etiology, and the genes involved in these malignancies.